$3.570
-0.020 (-0.56%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
PRME 相似圖表分析預測
Alphio's PRME stock price prediction model matches the current Prime Medicine, Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.48 (-2.66%). The 1-week path is $3.49 (-2.16%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Prime Medicine, Inc 股票嗎？
Prime Medicine Inc is a good buy right now due to its recent 6.49% increase over the last 5 days and a favorable RSI of 61.217, indicating bullish momentum. The positive arbitration ruling against Beam Therapeutics has removed a significant overhang, allowing the company to advance its PM647 treatment, which is expected to enter clinical trials soon. However, the main risk is the company's ongoing net losses, with a net income of -42,109,000 USD in Q2 2026, which highlights the financial challenges it faces as it seeks to commercialize its technology.
PRME 股價於 Tuesday 收在 $3.57，此前下跌 -0.56%
Prime Medicine, Inc (PRME) last closed at $3.57, losing -0.56%. These facts feed the 1-day and 1-week PRME price prediction above.
預測驅動因素
Prime Medicine, Inc（PRME）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
相似圖表形態
近期走勢與 PRME 最接近的股票，依相似度排序。
PRME 季節性分析
Historically the probability of a positive September return for PRME is 52.38%. January offers the highest probability of a positive month at 52.46%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。